ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Fluticasone

Also written as “Fluticasone Propionate”, “Fluticasone propionate” and “Fluticasone Propionate/Formoterol Fumarate”.

Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic · Rhinitis, Allergic, Perennial, led by 24 companies.

Drug pageFluticasone: every studyMany companies study it; this page follows only the 150 they lead. All 340 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Feb 1, 2005150 company-led studies, 5 open or runningNext primary completion: Dec 2026 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline580 open or runningphase 4since Feb 1, 2005Feb 1, 2005none ahead
Respirent Pharmaceuticalsits history only182 open or runningphase 3since Sep 17, 2018Sep 17, 2018none ahead
Teva Pharmaceutical Industriesits history only140 open or runningphase 4since Dec 11, 2020Nov 22, 2011none ahead
Viatrisits history only130 open or runningphase 4since Dec 16, 2016Nov 21, 2006none ahead
Optinose USits history only101 open or runningphase 3since Jun 13, 2012Jun 13, 2012Mar 31, 2028phase 3 · NCT06850805
Mundipharmaits history only60 open or runningphase 4since Jun 15, 2015Oct 14, 2009none ahead
SkyePharmaits history only50 open or runningphase 3since Oct 27, 2006Oct 27, 2006none ahead
Eurofarma Laboratoriosits history only31 open or runningphase 3since Sep 14, 2010Sep 14, 2010Aug 2028phase 3 · NCT06234345
Merckits history only30 open or runningphase 2since Oct 5, 2006Oct 5, 2006none ahead
Hikma Pharmaceuticalsits history only20 open or runningno phasesince Jan 5, 2016Jan 5, 2016none ahead

Also a collaborator on its studies: Paratek Pharmaceuticals, Becro, Prolytic, Dynamic Solutions, Parexel, Vectura and PPD DEVELOPMENT, LP.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of GlaxoSmithKline only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 44 studies since Feb 1, 2005.

  1. Aug 18, 2011Phase 2 study in RhinitisNCT01424397 · 70 enrolled · Austria
  2. Sep 15, 2011Phase 3 study in AsthmaNCT01435902
  3. Oct 27, 2011Phase 4 study in AsthmaNCT01462344 · 6,250 enrolled · United States, Argentina, Australia and more
  4. Nov 17, 2011Phase 4 study in AsthmaNCT01475721 · 11,751 enrolled · United States, Argentina, Australia and more
  5. Feb 23, 2012Phase 1 study in AsthmaNCT01540708 · 36 enrolled · Australia
  6. Mar 15, 2012Phase 2 study in AsthmaNCT01563029 · 597 enrolled · United States, Bulgaria, Georgia and more
  7. Aug 23, 2012Phase 3 study in AsthmaNCT01687283 · 316 enrolled · China
  8. Sep 6, 2012Phase 3 study in AsthmaNCT01687296 · 261 enrolled · China
  9. Dec 13, 2012Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT01751113 · 53 enrolled · Japan
  10. Mar 21, 2013Phase 3 study in Rhinitis, AllergicNCT01817790 · 626 enrolled · United States
  11. Jun 27, 2013Phase 4 study in Skin DiseasesNCT01915914 · 107 enrolled · China
  12. Mar 20, 2014Phase 3 study in AsthmaNCT02094937 · 430 enrolled · Japan
  13. Nov 24, 2014Phase 3 study in AsthmaNCT02301975 · 1,526 enrolled · United States, Argentina, Brazil and more
  14. Mar 24, 2016Phase 4 study in AsthmaNCT02730351 · 75 enrolled · United States, Canada

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 58 GlaxoSmithKline leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02730351Asthma · United States, Canada4CompletedFeb 3, 201775
NCT02301975Asthma · United States, Argentina, Brazil and more3CompletedNov 1, 20161,526
NCT02094937Asthma · Japan3CompletedAug 28, 2015430
NCT01915914Skin Diseases · China4CompletedFeb 15, 2015107
NCT01817790Rhinitis, Allergic · United States3CompletedFeb 2013626
NCT01751113Pulmonary Disease, Chronic Obstructive · Japan4CompletedNov 201353
NCT01687296Asthma · China3CompletedJun 1, 2013261
NCT01687283Asthma · China3CompletedNov 7, 2013316
NCT01563029Asthma · United States, Bulgaria, Georgia and more2CompletedSep 24, 2014597
NCT01540708Asthma · Australia1CompletedSep 4, 201236
NCT01475721Asthma · United States, Argentina, Australia and more4CompletedJun 23, 201511,751
NCT01462344Asthma · United States, Argentina, Australia and more4CompletedNov 1, 20156,250
NCT01435902Asthma3WithdrawnAug 20120
NCT01424397Rhinitis · Austria2CompletedJul 7, 201170
NCT01192178Asthma · United States4CompletedDec 2010339
NCT01156792Asthma · United States2CompletedOct 2011162
NCT01124422Pulmonary Disease, Chronic Obstructive · United States, Canada4CompletedMay 1, 2011255
NCT00984659Pulmonary Disease, Chronic Obstructive · United States4CompletedJul 1, 2010366
NCT00848965Rhinitis, Allergic, Perennial · Austria4CompletedJan 200859
NCT00784550Pulmonary Disease, Chronic Obstructive · United States4CompletedDec 2009342
NCT00633217Pulmonary Disease, Chronic Obstructive · United States4CompletedFeb 2009247
NCT00612820Rhinitis, Allergic, Seasonal · Austria2CompletedMay 200855
NCT00539006Rhinitis, Allergic, Perennial · United States4CompletedNov 2007377
NCT00519636Rhinitis, Allergic, Perennial · United States4CompletedNov 2007360
NCT00517634Asthma · United States, United Kingdom4CompletedJul 200823
NCT00503009Asthma · United States4TerminatedJul 200816
NCT00480649Asthma · Korea, Republic of4CompletedSep 2005424
NCT00456313Asthma · Netherlands4WithdrawnDec 20070
NCT00455923Asthma · Sweden4CompletedJul 31, 2007100
NCT00453778Asthma4CompletedMay 200414
NCT00452699Asthma · United States, Argentina, Brazil and more4CompletedMay 2009621
NCT00452348Asthma · United States, Argentina, Brazil and more4CompletedApr 2009628
NCT00448435Asthma · Japan3CompletedJan 200851
NCT00441441Asthma · United States, Australia, Canada and more3CompletedJan 2008351
NCT00400855Asthma · New Zealand2CompletedAug 200549
NCT00398476Rhinitis, Allergic, Perennial · United States3CompletedDec 4, 2006127
NCT00370591Asthma · United Kingdom4CompletedApr 200448
NCT00370097Asthma · United States1CompletedApr 12, 200716
NCT00369993Asthma · New Zealand2CompletedMay 200520
NCT00364442Asthma · Germany1CompletedApr 13, 200512
NCT00363480Asthma · Germany4CompletedSep 1, 2007221
NCT00358358Pulmonary Disease, Chronic Obstructive · United States, Chile, Estonia and more4CompletedFeb 2007163
NCT00353873Asthma · Belgium, Denmark, France and more4CompletedOct 26, 2006506
NCT00351143Asthma · Denmark, Switzerland4CompletedJun 13, 2007274
NCT00348361Rhinitis, Allergic · Netherlands, United Kingdom1Completed48
NCT00315744Asthma · Germany4CompletedApr 12, 2007285
NCT00296530Asthma · United States4CompletedJul 2007600
NCT00296491Asthma · United States, Canada, Estonia and more4CompletedOct 2007725
NCT00291382Asthma · Belgium, Estonia, Finland and more4CompletedJul 2007150
NCT00273026Asthma · Canada4Terminated680
NCT00269087Pulmonary Disease, Chronic Obstructive · Japan3CompletedOct 1, 2006122
NCT00169546Asthma · New Zealand, United Kingdom4CompletedDec 200564
NCT00158834Asthma · Netherlands3Completed200
NCT00118716Bronchial Spasm · United States4CompletedApr 1, 2006248
NCT00118690Bronchial Spasm · United States4CompletedDec 2005227
NCT00115492Pulmonary Disease, Chronic Obstructive · United States, Canada4CompletedJun 2007797
NCT00102882Asthma · United States, Kenya, Peru and more4CompletedJan 2007547
NCT00102765Asthma · United States4CompletedApr 2007479

How it is read

Names in the registry

  • “Fluticasone Propionate”, 17 entries
  • “Fluticasone propionate”, 13 entries
  • “Fluticasone Propionate/Formoterol Fumarate”, 9 entries
  • “fluticasone propionate”, 7 entries
  • “fluticasone propionate/salmeterol”, 7 entries

Codes read as this program: NCX4251, FP100.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.